Accelerating regulation in response to COVID-19.

Bull World Health Organ ; 98(8): 514-515, 2020 Aug 01.

Article in English | MEDLINE | ID: covidwho-708526

ABSTRACT

ABSTRACT

Regulators are finding ways to support the expedited development and distribution of novel coronavirus-related vaccines, tests and treatments. Gary Humphreys reports.

Subject(s)

Coronavirus Infections/epidemiology; Drug Approval/organization & administration; Global Health; Pneumonia, Viral/epidemiology; Antiviral Agents/therapeutic use; Betacoronavirus; COVID-19; Drug Approval/statistics & numerical data; Drug Evaluation, Preclinical/methods; Humans; Pandemics; SARS-CoV-2; Time Factors; United States; United States Food and Drug Administration/organization & administration; United States Food and Drug Administration/statistics & numerical data; Viral Vaccines/administration & dosage

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Global Health / Drug Approval / Coronavirus Infections Type of study: Observational study / Prognostic study Topics: Traditional medicine / Vaccines Limits: Humans Country/Region as subject: North America Language: English Journal: Bull World Health Organ Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google